The effect of obesity on the contractile performance of isolated mouse soleus, EDL, and diaphragm muscles by Tallis, Jason et al.
  
The effect of obesity on the contractile 
performance of isolated mouse soleus, 
EDL, and diaphragm muscles 
 
Tallis, J, Hill, C, James, RS, Cox, VM & Seebacher, F 
 
Author post-print (accepted) deposited by Coventry University’s Repository 
 
Original citation & hyperlink:  
Tallis, J, Hill, C, James, RS, Cox, VM & Seebacher, F 2016, 'The effect of obesity on the 
contractile performance of isolated mouse soleus, EDL, and diaphragm 
muscles' Journal of Applied Physiology, vol 122, no. 1, pp. 170-181 
https://dx.doi.org/10.1152/japplphysiol.00836.2016  
 
DOI 10.1152/japplphysiol.00836.2016 
ISSN 8750-7587 
ESSN 1522-1601 
 
Publisher: American Physiological Society 
 
Copyright © and Moral Rights are retained by the author(s) and/ or other copyright 
owners. A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge. This item cannot be reproduced or quoted extensively 
from without first obtaining permission in writing from the copyright holder(s). The 
content must not be changed in any way or sold commercially in any format or medium 
without the formal permission of the copyright holders.  
 
This document is the author’s post-print version, incorporating any revisions agreed during 
the peer-review process. Some differences between the published version and this version 
may remain and you are advised to consult the published version if you wish to cite from 
it.  
 
 1 
THE EFFECT OF OBESITY ON THE CONTRACTILE PERFORMANCE OF ISOLATED 1 
MOUSE SOLEUS, EDL AND DIAPHRAGM MUSCLES 2 
 3 
JASON TALLIS1 (), CAMERON HILL1, ROB S. JAMES1, VAL M. COX1, FRANK 4 
SEEBACHER2  5 
 6 
1Centre for Applied Biological and Exercise Sciences, Faculty of Health and Life Sciences, Coventry 7 
University, Coventry, CV1 5FB, U.K 8 
  9 
2School of Life and Environmental Sciences A08 University of Sydney, Science Road, Sydney, NSW, 10 
2006, Australia 11 
 12 
Email: tallisj2@uni.coventry.ac.uk 13 
 14 
 15 
RUNNING HEAD: OBESITY EFFECTS ON SKELETAL MUSCLE CONTRACTILITY 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
 29 
 30 
 31 
 32 
 33 
 34 
 35 
 36 
 37 
 38 
 39 
 40 
 41 
 42 
 43 
 44 
 45 
 46 
 47 
 48 
 49 
 50 
 51 
 52 
 53 
 54 
 55 
 56 
 57 
 58 
 59 
 60 
 2 
 61 
ABSTRACT 62 
 63 
Obesity affects the major metabolic and cellular processes involved in skeletal muscle contractility. 64 
Surprisingly, the effect of obesity on isolated skeletal muscle performance remains unresolved. The 65 
present study is the first to examine the muscle specific changes in contractility following dietary 66 
induced obesity using an isolated muscle work-loop (WL) model that more closely represents in vivo 67 
muscle performance. Following 16-week high calorific feeding, soleus (SOL), extensor digitorum 68 
longus (EDL), and diaphragm (DIA) were isolated from female (CD-1) mice and contractile 69 
performance compared against a lean control group. Obese SOL produced greater isometric force, 70 
however isometric stress (force per unit muscle area), absolute WL power and normalised WL power 71 
(watts per kg muscle mass) were unaffected. Maximal isometric force and absolute WL power of the 72 
EDL was similar between groups. For both EDL and DIA, isometric stress and normalised WL power 73 
were reduced in the obese groups. Obesity caused a significant reduction in fatigue resistance in all 74 
cases. Our findings demonstrate a muscle specific reduction in contractile performance and muscle 75 
quality that is likely related to in vivo mechanical role, fibre type and metabolic profile, which may in 76 
part be related to changes in MyHC expression and AMPK activity. These results infer that beyond the 77 
additional requirement of moving a larger body mass, functional performance and quality of life may 78 
be further limited by poor muscle function in obese individuals. As such, a reduction in muscle 79 
performance may be a substantial contributor to the negative cycle of obesity. 80 
 81 
 82 
NEW AND NOTEWORTHY 83 
 84 
The effect of obesity on isolated muscle function is surprisingly under researched. The present study is 85 
the first to examine the effects of obesity on isolated muscle performance using a method that more 86 
closely represents real word muscle function. This work uniquely establishes a muscle specific profile 87 
of mechanical changes in relation to underpinning mechanisms. These findings may be important to 88 
understanding the negative cycle of obesity and in designing interventions for improving weight status. 89 
 90 
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 121 
INTRODUCTION  122 
 123 
Obesity is a global epidemic, attributed to calorific rich foods and reduced physical activity (45). 124 
Associated health complications such as metabolic syndrome, cardiovascular disease, diabetes, 125 
musculoskeletal disorders, and some cancers (17) contribute to mortality, poor quality of life and 126 
significant financial implications for healthcare providers (2, 18, 22). If energy intake is not balanced 127 
with expenditure, adipose tissue accumulation occurs and is stored viscerally, subcutaneously and 128 
ectopically in organs, including skeletal muscle (3). Skeletal muscle is the largest regulator of 129 
metabolism in the body and contractility is needed to produce movement, highlighting the importance 130 
of investigating the effect of elevated lipid content on this tissue. Presently it is not clear whether lipid 131 
accumulation attenuates skeletal muscle contractility. 132 
 133 
Previous in vitro studies suggest that obesity may improve absolute strength of ‘antigravity’ muscles, 134 
but has little effect on musculature that is not loaded with an increased body mass (see review 39). For 135 
example, Rolland, Lauwers-Cances, Pahor, Fillaux, Grandjean and Vellas (50) reports an increase in 136 
the absolute force generating capacity of the knee extensors in obese elderly women, without 137 
significant changes in handgrip strength. These results are not surprising given the potential training 138 
adaptation that may occur due to the increased demand placed on the postural muscles during standing 139 
and locomotion (20). Interestingly, the small number of studies examining muscular fatigue have 140 
conflicting findings (37, 38, 40, 42, 47). Although variation in experimental methods and participants 141 
(i.e. differences in muscle groups tested, mode of exercise, age and gender of population) make 142 
comparisons between these studies difficult, the authors argue that the true effect of obesity on 143 
muscular endurance cannot be accurately evaluated in vivo, as irrespective of exercise intensity, 144 
musculature of the obese group will have to produce greater force to overcome greater inertia of the 145 
moving limb. Further limitations also arise when relating the principle findings of this body of work 146 
directly to skeletal muscle function.  147 
 148 
The majority of human studies measure muscular strength (39), and although this is an important 149 
mechanical parameter, dynamic power is needed for locomotion. Strength assessments largely involve 150 
gross joint movements and are influenced by neuromuscular recruitment, making it impossible to 151 
accurately examine the direct skeletal muscle and potential phenotype specific effects. Many human 152 
studies examine muscle performance normalised to body mass (1, 7, 9, 43, 47, 64), which provides 153 
little information regarding muscle quality (force relative to muscle mass). An obesity induced 154 
reduction in muscle quality could result in an increased maintenance cost due to a larger muscle mass, 155 
and consequently an increase in body mass, even before considering further lipid accumulation 156 
elsewhere in the body. Although some studies have normalised muscle performance to local and more 157 
commonly whole body lean mass (1, 7, 43, 47, 64), such assessments would not be as accurate at 158 
evaluating muscle quality as an in vitro isolated muscle approach, where whole muscle mass can be 159 
measured.  160 
 161 
Obesity has been associated with a reduction in myogenesis (4, 12), degeneration in the process of 162 
excitation contraction coupling and impaired calcium handling (8, 10, 19, 51), which may 163 
mechanistically account for a decline in contractility and muscle quality. Importantly, skeletal muscle 164 
lipid accumulation can affect metabolic capacity and phenotype composition, but the literature is 165 
equivocal with evidence of a shift to a faster, slower and no change in fibre type composition (13, 14, 166 
33, 34, 52, 59-61, 65). This ambiguity can largely be attributed to the different muscles tested, duration 167 
of the feeding period, and limitations in methods for quantifying fibre types. It has been further 168 
demonstrated that initially muscular lipid accumulation results in increases in oxidative enzymes, 169 
mitochondrial function, and slow MyHC (myosin heavy chain) expression, and in the long term, causes 170 
a reduction in oxidative enzymes, type I muscle fibre protein content, mitochondrial size and function 171 
(13). In skeletal muscle, glucose and fatty acid metabolism as well as mitochondrial function are at 172 
least partly regulated by AMP-activated protein kinase (AMPK) (46). Levels of adiponectin, a protein 173 
hormone produced by adipocytes that induces AMPK activity, are decreased by obesity in skeletal 174 
muscle (66), which may significantly influence skeletal muscle function.  175 
 176 
Despite this evidence, there is a distinct dearth of literature that directly assesses the effects of obesity 177 
on skeletal muscle contractility. Warmington, Tolan and McBennett (65) demonstrated little effect on 178 
the isometric twitch force of both whole extensor digitorum longus (EDL) and soleus muscle isolated 179 
from 5 month old genetically obese (Ob/Ob) mice when compared to a genetically normal control. 180 
 4 
However, maximal isometric tetanus force was significantly reduced in the Ob/Ob soleus with no effect 181 
in EDL. In part, these findings were later confirmed by Bruton, Katz, Lännergren, Abbate and 182 
Westerblad (8), reporting no changes maximal isometric force, but a significant improvement in 183 
isometric force using a submaximal stimulation of whole EDL and single flexor digitorum brevis 184 
muscle fibres isolated from 3-5 month old Ob/Ob mice. Similarly, Ciapaite, van den Berg, Houten, 185 
Nicolay, van Dijk and Jeneson (10) reported that isometric twitch and tetanus force of whole EDL was 186 
unaltered in 12 week old mice that consumed either a high fat lard or high fat palm oil diet for 5 weeks. 187 
However, the peak contractile performance of the soleus muscle was significantly reduced in animals 188 
fed a high fat palm diet but unchanged in animals fed a high fat lard diet. These results indicate that the 189 
source of the lipid overload may be an important factor for determining skeletal muscle responses to 190 
obesity, and are particularly interesting given the role of soleus as a postural muscle. 191 
 192 
The effect induced by genetic obesity may be different to that imposed by dietary-induced obesity. 193 
Contractile changes outlined in isolated muscle from Ob/Ob mice occurred in conjunction with a 194 
significant reduction in muscle mass (8, 65), where changes in contractility occurred following an 195 
elevated muscle mass in the dietary induced obesity model (10). In support, the ambiguity in obesity 196 
induced phenotype changes has been in part attributed to differing response between genetically and 197 
dietary induced obese models (14). Further work is needed to quantify the effects of dietary induced 198 
obesity on isolated skeletal muscle performance given its relevance to the real world obesity problem. 199 
In addition, previous isolated muscle work has used test temperatures between 20-26˚C (8, 10) limiting 200 
the application of findings to human skeletal muscle contractility. It should be noted that the contractile 201 
performance of skeletal muscle is greatly influenced by temperature (27) and further work is needed to 202 
evaluate change is muscle contractility using a more physiologically relevant thermal environment.  203 
 204 
Measurements of maximal isometric stress reveal little about changes in dynamic muscular 205 
contractility, which is an important aspect of real-world muscle function. In vivo, locomotory muscles 206 
rarely work at constant lengths and measures of isometric force fail to consider the important 207 
integration of the force-velocity relationship, the ability of the muscle to produce work during 208 
shortening, and the passive resistance to stretch needed to accurately assess muscle power (28, 31, 32). 209 
Furthermore, demonstrated increases in muscle activation times and, more commonly, relaxation time 210 
(8, 10), will have profound effects on the ability of the muscle to produce power. The effect of obesity 211 
on the fatigue resistance of isolated skeletal muscle is also unresolved.  212 
 213 
The present study examines the effects of dietary induced obesity on the maximal power output and 214 
fatigue resistance of soleus (slow twitch), EDL (fast twitch), and diaphragm (mixed fibre type) muscle, 215 
isolated from young adult mice, at a test temperature of 37˚C. By determining MyHC expression and 216 
AMPK activity, the present study will attempt to gain a better understanding of the muscle specific 217 
mechanisms causing the hypothesised decline in contractile performance. Importantly, the present work 218 
is the first to accurately determine the obesity induced muscle specific changes in quality using the 219 
work loop technique as a more accurate assessment of real life muscle function (28, 31, 32). By further 220 
examining muscle specific changes in absolute force, power and contractile performance relative to 221 
muscle mass, findings of the present work can be better applied to the real world locomotor 222 
performance of the whole animal. The results of the present work will allow a greater understanding of 223 
the specific role of skeletal muscle in the obesity induced reduction in physical activity, and the 224 
potential that a reduction in contractile performance, including muscle quality, may be a significant 225 
contributor to the obesity problem. 226 
 227 
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 243 
METHODOLOGY 244 
 245 
ANIMAL MORPHOLOGY 246 
 247 
The procedures outlined in this study and the use of animals was approved by the ethical committee of 248 
Coventry University. At 4 weeks of age, 56 CD1 female mice (Harlan, UK) were randomly split into 249 
either an Obese or a Lean Control group. Each group were matched for body mass and snout to anus 250 
length (n=28 in each case). For the next 16 weeks the Lean Control group were kept in cages of 8-10 251 
individuals in 12:12-h light-dark cycle and were provided with water and standard lab chow (SDS 252 
maintenance diet, Dietex International LTD; calories provided by Protein 17.5%, Fat 7.4%, 253 
Carbohydrate, 75.1%; Gross Energy 3.52 Kcal/g; Metabolisable Energy 2.57 Kcal/g) ad libitum. The 254 
Obese group were kept in identical conditions, but additionally were free to consume laboratory 255 
supplied forage diet (PicoLab® Natural Sunflower; calories provided by Protein 18.0%, Fat 63.7%, 256 
Carbohydrate, 18.4%; Gross Energy 5.2 Kcal/g; Metabolisable Energy 3.8 Kcal/g). Following the 257 
treatment period, animals were weighed and snout to anus length measured. These data were then used 258 
to calculate body mass index (BMI) and Lee index (weight0.33 (g)/Naso-Anal Length (cm); 53)  of 259 
obesity for each individual. 260 
 269 
Animals were then sacrificed by cervical dislocation (in accordance with British Home Office Animals 270 
(Scientific Procedures) Act 1986, Schedule 1) and the subcutaneous fat pad around the top of the hind 271 
limbs and genitals was extracted and weighed. In addition, either whole SOL, EDL or DIA muscle was 272 
dissected from each individual in refrigerated (1-3°C) oxygenated (95% O2; 5% CO2) Krebs Henseleit 273 
solution (NaCl 118; KCl 4.75; MgSO4 1.18; NaHCO3 24.8; KH2PO4 1.18; glucose 10; CaCl2 2.54 mM 274 
in each case; pH 7.55 at room temperature prior to oxygenation). The left limb muscle or right half 275 
section of the DIA was immediately snap frozen in liquid nitrogen and stored in a -80°C freezer for 276 
later biochemical analysis. The remaining limb muscle, or a ventral section of the costal DIA, was used 277 
in the study of skeletal muscle contractility. 278 
 279 
 280 
CONTRACTILTIY MEASURES 281 
 282 
The tendon attachment at the proximal end of both the SOL and EDL were left intact and aluminium 283 
foil T-clips were wrapped around the distal tendon as close to the muscle as possible. For the DIA, 284 
aluminium foil T-clips were wrapped around the central tendon at one end, and at the opposing end, 285 
two ribs anchoring the muscle were left intact. 286 
 287 
Mechanical performance was measured using custom designed equipment. Each muscle preparation 288 
was placed in a Perspex chamber filled with circulating oxygenated Krebs maintained at a 289 
physiologically relevant 37°C. Using the intact bone or aluminium clips, the muscle preparation was 290 
attached to a force transducer (UF1, Pioden Controls Ltd, UK) and a motor (V201, Ling Dynamic 291 
Systems, UK) at each end via crocodile clips. The muscle was electrically stimulated to produce force 292 
via parallel platinum electrodes submerged in the Krebs solution inside the muscle chamber. 293 
Stimulation and length change parameters were controlled using custom written software (Testpoint, 294 
CEC, Massachusetts, USA) via a D/A board (KPCI3108, Keithley Instruments, Ohio, USA) on a 295 
standard desktop PC. 296 
 297 
Initially muscle length and stimulation amplitude (typically 12-16V for SOL and DIA, 14-18V EDL) 298 
were adjusted to produce a maximal isometric twitch response. Using these parameters, the muscle was 299 
then subjected to a train of electrical stimuli (350ms for SOL, and 250ms EDL & DIA) with 300 
stimulation frequency adjusted (usually 120Hz for SOL, 200Hz for EDL & 140Hz for DIA 301 
respectively) to evoke a maximal isometric tetanus response. Time to half peak Tetanus (THPT) and 302 
time from the last stimulus to half relaxation (LSHR) was measured for the maximal tetanus response 303 
as a measure of activation and relaxation time. A 5-minute rest period was imposed between each 304 
tetanus. 305 
 306 
The optimal muscle length (L0) for maximal twitch force, determined by the isometric tests, was 307 
measured using an eyepiece graticule fitted to a microscope and estimates of mean fibre length were 308 
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determined as 85% of the physical length for SOL and 75% for EDL (28). No such estimates of fibre 309 
length have been reported for DIA, so the physical length measurement was use to represent L0. This 310 
approach has been standard practice in previous work using these muscles (23, 28, 31, 55, 58). 311 
 312 
Muscle power output was measured using the work loop (WL) technique. The method allows a more 313 
accurate assessment of muscle power and is a closer representation of the contractile mechanics used 314 
by power producing muscles in vivo (31, 32). Unlike other isolated muscle studies in this area that 315 
examined isometric force (8, 10, 65), the WL considers the interaction of force production during 316 
shortening, the force velocity relationship and work required to re lengthen the muscle in preparation 317 
for subsequent contraction (28, 31, 32). The in vivo relevance of this technique and its application has 318 
been outlined in our previous work (29, 54, 57, 58). Each muscle is subjected to a symmetrical 319 
sinusoidal length change around the previously determined optimal length and stimulated to produce 320 
force during the shortening phase. Length changes were implemented by a motor and position of the 321 
motor arm was measured using Linear Variable Displacement Transformer (DFG5.0, Solartron 322 
Metrology, UK). Instantaneous force and velocity were sampled, throughout the length change cycle, at 323 
a rate of 10 kHz and plotted against each other to form a work loop. Net work is calculated as the 324 
positive work produced during shortening, minus the work required to lengthen the muscle.  325 
 326 
Electrical stimulation during the WL was delivered to the muscle at the optimal frequency and 327 
amplitude determined in the isometric tests. Strain (amplitude of length change), stimulus phase and 328 
burst duration were optimised to elicit maximal net work at cycle frequencies of 5Hz, 10Hz, and 7Hz 329 
for SOL, EDL and DIA respectively. Cycle frequency denotes the rate at which the work loops were 330 
performed and these cycle frequencies have been shown to elicit maximal PO in these muscles (6, 28). 331 
Typically, a strain of 0.10 of L0 was used to produce maximal net work in each muscle. As such, the 332 
muscle increased in length by 5%, shortened by 10%, then was re-lengthened by 5% back to L0. If the 333 
burst duration is too short, the muscle will not produce high amounts of force through the shortening 334 
phase (decreased positive work), too long and the muscle will be active during the re-lengthening phase 335 
(increased negative work). The optimal phase was typically -10ms for SOL, -2 ms for EDL and –5ms 336 
for DIA, indicating the start of stimulation with respect to maximal muscle length during the length 337 
change cycle. i.e. stimulation starts before maximal length is reached so that force has risen before 338 
shortening begins. The typical values for strain, burst duration and phase align with the values used to 339 
elicit maximal power output at these cycle frequencies in previous studies (23, 28, 29, 57, 58). Each 340 
muscle was subjected to four work loop cycles per run, with 5-minute rest intervals between each run.  341 
 342 
Fatigues resistance was measured by subjecting each muscle to 50 consecutive work loop cycles at the 343 
parameters that elicited maximal power output. The decline in maximal power was plotted against time 344 
until each muscle produced less than 50% of its pre fatigue maximal power output. Similar methods 345 
have been employed in previous work using the work loop technique to examine the fatigability of 346 
muscle power (23, 58). 347 
 348 
Finally, the muscle was detached from the equipment and tendons and bone removed. Each muscle was 349 
then blotted on absorbent paper, to remove excess Krebs solution, and placed on an electronic balance 350 
(Mettler Toledo B204-S, Zurich, Switzerland) to determine wet mass. Mean muscle cross-sectional 351 
area was calculated from L0, muscle mass and an assumed muscle density of 1060 kg m-3 (41). 352 
Isometric stress was calculated as maximal tetanic force divided by mean muscle cross-sectional area. 353 
Muscle power output was normalised to muscle mass to express power as Watts.kg-1. 354 
 355 
BIOCHEMISTY 356 
 357 
Fast and slow myosin heavy chain (MyHC) expression was measured to examine changes in fibre type 358 
composition and 5' AMP-activated protein kinase (AMPK) and phosphorylated AMPK were measured 359 
as an indicator of muscle metabolic responses. Proteins were extracted in RIPA buffer (Tris CL 20 360 
mM, NaCl 150 mM, EDTA 1 mM, EGTA 1mM, NP40 1%, Na deoxycholate 1%, pH 7.5) with the 361 
addition of a protease and phosphatase inhibitor cocktail (Roche, Sydney, Australia). Protein 362 
concentrations were determined by capillary electrophoresis in a "Wes" Simple Western system 363 
(Protein Simple, Santa Clara, CA, USA) according to the manufacturer's instructions. All antibodies 364 
were from Abcam (Cambridge, MA, USA), and we determined concentrations of total fast (ab51263) 365 
and slow (ab11083) skeletal myosin heavy chains, AMPK alpha 1 + 2 (ab80039), phosphorylated 366 
AMPK alpha 1 (phosphorylated at T173) and 2 (phosphorylated at T172; ab133448), and -tubulin 367 
(ab80779) as internal control (35). Note that AMPK is activated by phosphorylation so that activity of 368 
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AMPK is expressed by the ratio between phosphorylated (pAMPK) and total AMPK concentrations 369 
(63). All antibody and protein concentrations were optimized following the manufacturer's 370 
recommendations. All samples were run in duplicate and we interspersed samples from different 371 
treatments on the same plate. 372 
 373 
STATISTICAL METHOD 374 
 375 
Following appropriate checks of normality and homogeneity, morphological, contractile and protein 376 
data was analysed using two-tailed independent samples T-Tests. On the small number of occasions 377 
where the data was not normally distributed Mann-Whitney U tests were performed. Where the work 378 
loop power of the muscles extracted from obese animals was statistically different from lean controls, 379 
Spearman’s rank correlations were performed to assess the relationship between body mass and 380 
normalised work loop power to determine if the magnitude of obesity effected muscle performance. 381 
Further Spearman’s rank correlations were performed to analyse the relationship between 382 
morphological measures. 383 
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RESULTS 434 
 435 
MORPHOLOGY 436 
 437 
Whole animal body mass, fat pad mass, BMI and Lee index of obesity were significantly greater in the 438 
obese group when compared to controls (Table 1; Mann-Whitney P<0.001 for body mass & fat pad 439 
mass; T-Test P<0.001 for BMI & Lee Index). Body length was not significantly different (Table 1 440 
Mann-Whitney P=0.053). When broken down into each treatment group whole animal body mass, BMI 441 
and Lee index of obesity were significantly greater in the obese groups when compared to the lean 442 
controls (Table 2 P<0.05 in all cases). For both the SOL and EDL, obese muscle mass was significantly 443 
greater (Table 2 T-Test P<0.03 in each case) but muscle length was not affected (Table 2 T-Test 444 
P=0.80 for SOL; Mann-Whitney P=0.15 for EDL).  445 
 446 
Within the obese group, measures of body mass correlated well with body length and fat pad mass 447 
(Spearmans’ r> 0.4 P<0.03 in each case), In addition, fat pad mass was strongly associated with greater 448 
BMI and Lee index (Spearmans’ r> 0.7 P<0.003 in both cases).   449 
 450 
ISOMETRIC STRESS  451 
 452 
For SOL, absolute maximal isometric force was significantly higher in the obese group compared to 453 
the lean control (Fig 1B T-Test P=0.003), however maximal isometric stress was not significantly 454 
different (Fig 1A T-Test P=0.38). The absolute maximal isometric force generated by the EDL was not 455 
significantly different between the obese and the lean group (Fig 1D T-Test P=0.20), however maximal 456 
isometric stress was significantly reduced in the obese group (Fig 1C T-Test P<0.005). Similarly, the 457 
maximal isometric stress of obese DIA was significantly lower than lean controls (Fig 1E T-Test 458 
P<0.001). Absolute force and power was not assessed for the DIA as only a section of this muscle was 459 
used in the examination of contractile performance. 460 
 461 
THPT was not significantly different between the obese and the lean control group for SOL, EDL or 462 
DIA (Table 3 P>0.24 in each case). Similarly, LSHR for EDL was not significantly different between 463 
the obese and lean group (Table 3 T-Test P=0.67). In the obese SOL, LSHR was significantly 464 
prolonged (Table 3 T-Test P=0.01), whilst in obese DIA, LSHR was significantly shorter when 465 
compared to the controls (Table 3 Mann-Whitney P=0.02). 466 
 467 
WL PO & FATIGUE RESITANCE 468 
 469 
For both the SOL and EDL, absolute WL power was not significantly different between the obese and 470 
the lean groups (Fig 2B & D T-Test P>0.44 in each case). When normalised to muscle mass, SOL WL 471 
power was not significantly affected (Fig 2A Mann-Whitney P=0.30), however normalised power was 472 
significantly reduced in the obese DIA and EDL (Fig 2C & E T-Test P<0.006 in each case). For the 473 
obese group there was no significant relationship between normalised WL power and body mass for 474 
EDL (Fig 3A Spearmans’ r=-0.183 P=0.64), however Obese DIA extracted from animals with a larger 475 
body mass had significantly reduced performance (Fig 3B Spearmans’ r=-0.714 P=0.047).  476 
 477 
SOL from the obese group fatigued significantly faster than lean controls (Fig 4A T-Test P=0.002). 478 
There were no significant differences in the fatigue response for either the EDL or DIA (Fig 4B & C T-479 
Test P>0.8 in each case). 480 
 481 
 482 
PROTEIN EXPRESSION 483 
 484 
SOL in obese mice had significantly less slow MyHC/α-Tubulin (Fig 4A T-Test P=0.01); fast 485 
MyHC/α-Tubulin showed a similar trend but the data were more variable so that there was no 486 
significant difference between obese and lean SOL (Fig 4B T-Test P= 0.16), and the ratio between 487 
slow and fast MyHC did not differ (Fig 4C Mann-Whitney P=0.82). DIA had significantly greater slow 488 
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and fast MyHC/α-Tubulin in obese animals compared to the lean group (Fig 2G, H T-Test P<0.04 in 489 
each case), and there was no difference in the ratio between slow and fast MyHC between treatment 490 
groups (Fig 4I T-Test P= 0.23). Slow MyHC/α-Tubulin and Fast MyHC/α-Tubulin were not 491 
significantly different between the obese and lean EDL (Fig 4D, E T-Test P=0.83 & Mann-Whitney 492 
P=0.60 respectively), and there was no difference in the ratio between slow and fast MyHC between 493 
treatment groups (Fig 4F T-Test P=0.53) 494 
 495 
AMPK/α-Tubulin, pAMPK/α-Tubulin and pAMPK/AMPK were significantly reduced in the obese 496 
SOL group compared to lean controls (Fig 6 A, B, C T-Test P<0.007 in each case). Conversely 497 
AMPK/α-Tubulin, pAMPK/α-Tubulin and pAMPK/AMPK were significantly greater in the obese DIA 498 
(Fig 6 G, H, I T-Test P<0.03 in each case).  AMPK/α-Tubulin was lower in the obese EDL and this 499 
was approaching statistical significance (Fig 6D T-Test P=0.05), however pAMPK/α-Tubulin and 500 
pAMPK/AMPK were unchanged (Fig 6E, F T-Test P>0.05 in both cases). 501 
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 554 
DISCUSSION 555 
 556 
Our results indicate that obesity causes a decline in the contractile performance of isolated skeletal 557 
muscle. These findings are the first to offer a detailed insight into the direct changes in absolute 558 
contractile performance and muscle quality using a methodological approach which more closely 559 
represents the environmental conditions and contractile mechanics of skeletal muscle in vivo. The 560 
present findings indicate that the decline in contractile performance is likely to relate to fibre type 561 
composition, metabolic profile and the in vivo mechanical role of each muscle. 562 
 563 
THE EFFECT OF OBESITY ON MAXIMAL FORCE AND POWER 564 
 565 
The absolute isometric force of the obese SOL was significantly greater than the lean control group. 566 
This result is unsurprising given the role of SOL in postural control and proposed training stimulus 567 
evoked by the elevated body mass. Similar increases in the absolute strength of ‘antigravity’ muscles 568 
have been reported in previous in vivo literature (See review by 39). Interestingly, this increase in force 569 
producing capacity did not transfer to an increase in the absolute power output produced by SOL. 570 
These findings may suggest an obesity induced favourable adaptation for the SOL in static isometric 571 
contractions needed for such activities as quiet standing, which does not necessarily transfer to an 572 
improvement in locomotor performance given that when producing power in vivo, SOL of the obese 573 
group would be working to move a greater whole animal body mass. Isometric stress and normalised 574 
WL power were unaffected in the SOL, possibly demonstrating that the muscle quality of the obese 575 
group was maintained. Given that normalised WL power was also unaffected, one would anticipate a 576 
similar increase in absolute power given the increase in muscle mass. Surprisingly this was not 577 
demonstrated in the statistical results and maybe attributed to the large variation in this data set. 578 
 579 
The maximal isometric stress and normalised work loop power output was significantly reduced in the 580 
obese EDL. With respect to the limited changes in absolute isometric force and work loop power, and 581 
increase in muscle mass, these results infer that in the case of the obese EDL, larger muscles of poorer 582 
quality are formed to maintain the same absolute contractile performance as the lean counterparts. In 583 
vivo this would present two significant problems. Firstly, although absolute performance is maintained, 584 
larger muscles will add to the whole animal body mass thus increasing body inertia. Given this and the 585 
significant increase in body mass that will arise via adipose tissue accumulation, the maintenance of 586 
absolute force and power is likely to be inadequate given the increase in load. Similar to the EDL, 587 
isometric stress and normalised WL power of the obese DIA was significantly lower compared to the 588 
lean control group. This again suggests that there is a significant reduction in muscle quality. 589 
 590 
As expected with dietary induced obesity models, there was a large variation in the body mass for the 591 
obese group. Interestingly, the obese DIA muscles that were extracted from animals with a higher body 592 
mass had significantly lower normalised WL power. This possibly indicates a negative relationship 593 
between the quantity of adipose tissue and muscle quality for this muscle. No such effects were 594 
demonstrated for the EDL, however it is clear from the data that this response needs to be analysed 595 
using a larger sample size. Further exploration is also needed considering the distribution of adipose 596 
tissue deposits at a whole body and muscle specific level to determine whether increased body mass is 597 
linked to increased intramuscular adipose tissue. 598 
 599 
Given the mechanical role and fibre type composition of each muscle used in the present work, it is 600 
unsurprising to see a muscle specific response to lipid accumulation. With the SOL being composed 601 
primarily of slow oxidative fibres, it could be considered that this muscle already has a preferable 602 
metabolic profile to oxidise lipids, in comparison to EDL and DIA which have a relatively faster fibre 603 
type composition. Similar sentiments have been reported in previous literature (10). As such it is 604 
possible that lipid accumulation in the SOL would be less than the other muscle tested, thus potentially 605 
delaying the onset of degenerative mechanisms. Although it could be considered that the mechanical 606 
loading of the EDL and DIA may be increased (larger foot and thoracic cavity mass respectively), the 607 
magnitude of which is likely to be lower that the SOL due to its role in postural support. 608 
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It is clear from the contractile evidence demonstrated here and that of previous literature (20, 50), that 609 
an increased load may evoke a substantial training stimulus to promote muscle adaptation. However, 610 
one would expect a progressive resistance training program to evoke increases in both contractile 611 
protein quantity (mass) and quality (24, 26, 49), which was not demonstrated in our obese model. This 612 
may inadvertently point to defects in the process of myogenesis which has previously been reported as 613 
a consequence of obesity (4, 12).  614 
 615 
THE EFFECT OF OBESITY ON FATIGUE RESISTANCE 616 
 617 
Although a number of in vivo studies demonstrated an obesity associated reduction in the ability to 618 
sustain locomotor performance (16, 48), and more specifically skeletal muscle force production (38), in 619 
reality this evidence tells us little about the direct effect of obesity on skeletal muscle performance. It is 620 
likely that skeletal muscle of an obese experimental group will fatigue much faster in vivo than a lean 621 
group, irrespective of exercise intensity, due to elevated body inertia. To date the effect of obesity on 622 
the fatigue resistance of isolated skeletal muscle has only been examined by Bruton, Katz, Lännergren, 623 
Abbate and Westerblad (8), who demonstrated reduced fatigue resistance of single flexor digitorum 624 
brevis fibres but no effect on the whole EDL of Ob/Ob mice following a bout of repeated tetanic 625 
stimulations at a submaximal intensity. The present findings uniquely examine the isolated skeletal 626 
muscle fatigue resistance following dietary induced obesity and using dynamic contractions to estimate 627 
changes in muscle power output. 628 
 629 
Despite the acute contractile performance of the SOL being reasonably well maintained, when 630 
subjected to a bout of repeated WL contractions, the obese SOL fatigued significantly faster than the 631 
lean control group. Such findings would indicate a significant limitation to sustained locomotory 632 
performance. Mechanistically, this may relate to the demonstrated reduction in slow MyHC expression. 633 
The ability to release and reuptake Ca2+ from and to the Sarcoplasmic Reticulum (SR) dictates the rate 634 
and magnitude of force production and relaxation. An obesity induced increase in tetanus relaxation 635 
time may point to a change in Ca2+ kinetics, particularly as previous research has demonstrated an 636 
obesity associated reduction in the function of SERCA, which is responsible for the movement of Ca2+  637 
from the cytoplasm back into the SR (19). If the muscle is still active during the re-lengthening phase 638 
of the work loop, this will significantly increase the work required to lengthen the muscle (negative 639 
work) and as a consequence, decrease the net work produced. An elevated relaxation time has been 640 
reported as a consequence of fatiguing contractions in normal conditions in some muscles (5), which 641 
given the present data is likely to be further exacerbated in the obese condition. Furthermore, obesity 642 
has been associated with a reduction in the efficacy of actin-myosin cross bridge cycling that may 643 
possibly occur independently of changes in SERCA (10, 51). 644 
 645 
Although the pattern of fatigue would appear to be unaffected in EDL and DIA, these data are plotted 646 
from 100% of maximal power obtained for each of the obese and the lean group. As such one should 647 
consider that the 100% power values for the obese group would be significantly lower in the obese 648 
group compared to the controls as outlined in the acute data. As such, if muscles of each group were to 649 
work at the same absolute intensity, the obese group would be working closer to maximum power 650 
compared to the lean group and subsequently will fatigue more quickly. 651 
 652 
This is the first evidence to demonstrate that the reduction in endurance capacity seen in vivo (16, 48) 653 
can be in part be attributed to a reduction in the fatigue resistance of skeletal muscle. The reduction in 654 
muscle fatigue resistance is likely to be further magnified in vivo by the elevated body inertia that will 655 
arise from an increase in body mass. The reduction in the fatigue resistance of the DIA could have 656 
further substantial consequences for in vivo performance. Limiting pulmonary function will 657 
subsequently affect the quantity of oxygen delivered to muscle throughout the body, and as a result the 658 
capacity to regenerate ATP. The delivery of oxygen to muscle is also fundamental for lipid oxidation, 659 
thus potentially limiting the ability to unitise lipid as an energy source during physical activity and thus 660 
further exacerbating accumulation. 661 
 662 
MECHANISMS 663 
 664 
Obesity has been shown to affect a number of important metabolic and cellular processes involved with 665 
force production. This data is vital in our understanding of mechanistic changes that occur, but given 666 
the dearth of research exploring both contractility and underpinning mechanisms, there is difficulty in 667 
mapping the muscle specific changes in contractile performance with specific mechanisms.  668 
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 669 
Although the reduction in slow MyHC expression may help to explain the reduced fatigue resistance in 670 
the SOL, the normalised force and power of the EDL and DIA occurred without a change in the ratio of 671 
fast and slow MyHC expression. Evidence examining the effect of obesity on muscle fibre type 672 
composition is varied (as discussed by 14). Although there is evidence demonstrating a shift to both a 673 
faster and slower phenotype in obese experimental groups (14, 33, 34, 52, 59, 61, 65), equally there is 674 
evidence reporting no change (13, 14, 52, 60). Interestingly, Warmington, Tolan and McBennett (65) 675 
demonstrate that despite a shift to a slower fibre type, the maximal force generating capacity of the 676 
muscle was unchanged in Ob/Ob mice. Interpretation and comparison of the evidence reported in 677 
previous literature is however subject to the same methodological discrepancies identified in studies 678 
measuring muscle performance. The present findings infer that fibre type shifts may play are role, but 679 
do not substantially explain the reduction in the obesity induced change in contractile performance. 680 
Given that the present data only examines 16 weeks of feeding, changes in fibre type expression could 681 
elicit more significant mechanical consequences following longer feeding periods. 682 
 683 
AMPK is an important regulator of energy homeostasis in the body, and more specifically, skeletal 684 
muscle (44, 46). A change in AMPK activity would result in a reduction in the ability to regenerate 685 
ATP via both glycolysis and fatty acid oxidation (44), and consequently may affect the contractile 686 
performance. Principally a change in muscular AMPK activity is likely to have little effect on the 687 
ability of the muscle to produce one off maximal force and power as the energy for this is expected to 688 
come from the small quantity of available ATP. However, the demonstrated reduced pAMPK/AMPK 689 
expression may help to further explain the significantly reduced time to fatigue in the obese SOL. The 690 
increase in pAMPK/AMPK in the obese DIA had little effect on the pattern of fatigue. Interestingly, in 691 
the obese DIA, when compared to the obese SOL, the results of the DIA may call into question the 692 
contribution of this mechanism to the given decline in obese SOL fatigability. However, it is likely that 693 
the demand for ATP per unit mass of tissue is much less in the obese DIA compared to the lean DIA 694 
given the significant reduction in normalised maximal power. Interestingly, despite a reduction in 695 
AMPK concentration in the obese EDL, pAMPK/AMPK was unchanged as was the pattern of fatigue.  696 
 697 
These findings in part support previous evidence demonstrating an obesity related changes in the 698 
metabolic profile of skeletal muscle (10, 13, 25). As indicated by (13), this response is likely to be 699 
muscle specific and its complexity relate to fibre type and duration of high fat diet consumption. 700 
Although there were some favourable effects for DIA, this had little effect on contractile performance. 701 
Irrespective of the muscle specific application, insufficient APMK activity in the muscle may further 702 
exacerbate lipid accumulation via reduced lipid oxidation and as such, may further promote the decline 703 
in contractile function through this and other mechanisms (46).  704 
 705 
As previously outlined, literature has demonstrated an obesity associated decline in muscle protein 706 
synthesis (4, 12). Degradation in the normal process of contractile protein maintenance and 707 
regeneration would have significant implications on mechanical performance. The increased quantity 708 
of both fast and slow myosin heavy chain expression in the obese DIA would conceivably contradict 709 
this previous evidence. These results would infer that the quantity of lean tissue was greater in the 710 
obese DIA, however the normalised contractile performance of this muscle was significantly reduced. 711 
In addition, the increase in the absolute force of SOL and the proposed similar concentrations on lean 712 
mass between obese and lean EDL (i.e. no change in slow and fast MyHC expression) were not 713 
coupled with improved or maintained muscle quality respectively. This suggests that although 714 
plasticity in skeletal muscle modelling is continued, the quality of the contractile protein produced is 715 
significantly reduced, thus supporting the demonstrated reduction in protein synthesis previously 716 
reported (4, 12). 717 
 718 
The results of the present work demonstrate a complex and muscle specific interaction in the down 719 
regulation of important processes that evoke contractility, which likely gives rise to the muscle specific 720 
decline in performance outlined in this study. The contribution of each of the proposed mechanisms is 721 
still unknown and is likely to change with obesity status. Furthermore, the demonstrated reduction in 722 
skeletal muscle performance may be further exacerbated in vivo given the reported changes in 723 
neuromuscular recruitment (67). As such a mechanism for the reduction in muscle quality and 724 
subsequent compensatory increase in size may be due to obesity induced denervation affecting the 725 
ability to efficiently recruit fibres. However, given the lack of studies in this area, it is not clear whether 726 
a reduction in recruitment is a cause or a consequence of the skeletal muscle obesity response. 727 
 728 
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LIMITAIONS & FUTURE DIRECTION 729 
 730 
Although isometric stress and normalised WL power provide an accurate assessment of muscle quality 731 
per unit of muscle mass, it is considered that in the obese group a smaller proportion of the total mass 732 
will be contractile protein due to the greater infiltration and accumulation of lipids. Normalising 733 
contractile performance to lean tissue mass would allow further consideration of how much the change 734 
in muscle quality is related to changes in lipid accumulation. However, there are significant 735 
methodological problems with accurately obtaining measure of muscular lipid and contractile mass. 736 
Previous work has indicated that obesity can cause a two fold increase in skeletal muscle lipid content 737 
(21). Machann, Bachmann, Brechtel, Dahl, Wietek, Klumpp, Haring, Claussen, Jacob and Schick (36) 738 
further demonstrated a muscle specific increase in the lipid content of skeletal muscle of obese 739 
individuals. The lipid content of the tibialis anterior (relatively fast twitch fibre composition) increased 740 
from 1.6% in normal weight individuals to 2.8% in obese individuals, and from 2.5% to 3.8% in the 741 
SOL. Given these findings, and that fat is less dense than lean muscle mass, it is likely the potential 742 
elevation in lipid content in the obese muscles of the present study will only be a minor contributor to 743 
the significant increase in muscle mass. As such, lipid storage itself is likely to only play a small role in 744 
the obesity associated reduction in muscle quality.  745 
 746 
Although the sinusoidal length change waveform used in the present study provides an approximation 747 
of in vivo cyclical muscle activities, it is a simplification of the length change waveforms used in real-748 
life locomotion (15). In particular during fatiguing contractions, the pattern of fibre stimulation and 749 
length change waveforms are likely to be manipulated throughout movement (62). Therefore, if a 750 
muscle is active as it begins to re-lengthen (i.e. producing too much eccentric force), the duration of 751 
stimulation is likely to be reduced in order to lessen the elevated negative work and any associated 752 
muscle damage. That considered, the model used in this study is appropriate to assess the decline in the 753 
ability of the muscle to produce maximal power during repeated contractions and is representative of 754 
the protocol used in other isolated skeletal muscle studies (23, 29, 30, 55, 56, 58).  755 
 756 
We followed published protocols in determining MyHC concentrations  (35). However, there is a 757 
suggestion in the literature (11) that using low salt buffers such as RIPA buffers underestimates the 758 
concentrations of MyHC. Our measures of MyHC concentrations may therefore be an underestimate, 759 
but this will not affect our comparisons between obese and lean individuals, or between the relative 760 
abundance of slow and fast MyHC within muscles. 761 
 762 
These results offer an important insight into the effects of obesity on the contractile performance of 763 
isolated skeletal muscle, however future work should consider examining contractile performance 764 
following a varied range of feeding periods. It is clear from the evidence in the literature that skeletal 765 
muscle mechanistic response is likely to change depending on duration of feeding and as a result it 766 
should be considered that the contractile performance will alter accordingly. Such work would be 767 
valuable in determining the muscle specific onset of obesity related changes in muscle performance 768 
and the potentially more severe implications of feeding regimes longer than that used in the present 769 
work. Given the importance of the present findings, it would also be of interest to repeat this work in an 770 
ageing animal model given the recent popularity in studies examining the relationship between obesity 771 
and sarcopenia. 772 
 773 
CONCLUSION 774 
 775 
The present findings demonstrate a muscle specific reduction in the contractile performance of isolated 776 
skeletal muscle which is likely related to a combination of in vivo mechanical role, fibre type 777 
expression and metabolic profile. The increase in the absolute isometric force of the SOL is 778 
unsurprising given the role of this muscle in postural support, however this increase occurred without a 779 
change in muscle quality (normalised force and power), potentially demonstrating detrimental effects 780 
of obesity on skeletal muscle plasticity and myogenesis. Although the absolute contractile performance 781 
of the EDL was maintained, muscle quality was significantly reduced. As such, in order for the obese 782 
group to maintain the same performance as the lean counterparts, larger muscles of lower quality were 783 
produced, thus further adding to in vivo force and power requirements needed to support and overcome 784 
the elevated whole animal body mass. The results are the first to assess the effect of obesity on fatigue 785 
resistance during power production in isolated skeletal muscle and demonstrate that obese mice would 786 
be unlikely to maintain the same absolute power output in SOL, EDL and DIA muscles for as long as 787 
lean animals. These results indicate that irrespective of the increase in body inertia, the reduction in 788 
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locomotory performance demonstrated in vivo can be in part attributed to a reduction in the fatigue 789 
resistance of skeletal muscle. The present results confirm that mechanistically, significant changes in 790 
contractile performance can occur in EDL and DIA without a change in fibre type composition. 791 
Although there is some previous evidence alluding to changes in metabolic profile, Ca2+ handling and 792 
protein synthesis, future work should focus on establishing the onset and extent of these mechanisms in 793 
relation to changes in contractile mechanics. In summary, a reduction in the contractile performance of 794 
skeletal muscle could be a significant catalyst to the negative cycle of obesity. Reducing the capacity to 795 
locomote and maintain adequate pulmonary function, is likely to contribute to a reduction in quality of 796 
life, exercise capacity and will sustain a significant calorific imbalance. 797 
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FIGURES 1127 
 1128 
Figure 1 – The effect of 16 weeks HFD on the maximal isometric tetanus stress and absolute isometric 1129 
tetanus force of isolated mouse SOL (A & B), EDL (C & D) and DIA (E) [Data represented as 1130 
Mean±SE; N=10 for SOL; N=10 for EDL lean; N=9 for EDL obese; N=8 for DIA; * represent 1131 
significant differences] 1132 
 1133 
Figure 2 – The effect of 16 weeks HFD on the maximal normalised WL PO and absolute WL PO of 1134 
isolated mouse SOL (A & B), EDL (C & D) and DIA (E) [Data represented as Mean±SE; N=10 for 1135 
SOL; N=10 for EDL lean; N=9 for EDL obese; N=8 for DIA; * represent significant differences] 1136 
 1137 
Figure 3 - The relationship between whole animal body mass and normalised work loop power for the 1138 
obese EDL (A) and DIA (B) experimental groups [N=9 for EDL; N=8 for DIA; The lines represent a 1139 
first-order polynomial fitted to the data using a least squares regression and the 95% confidence limits 1140 
of this line] 1141 
 1142 
Figure 4 - The effect of 16 weeks HFD on the fatigue resistance of maximally stimulated mouse SOL 1143 
(A), EDL (B) and DIA (C) [Data represented as Mean±SE; N=10 for SOL; N=10 for EDL lean; N=9 1144 
for EDL obese; N=8 for DIA; * represent significant differences] 1145 
 1146 
Figure 5 – The effect of 16 weeks HFD on fast and slow MyHC expression of mouse SOL, EDL and 1147 
DIA [Data represented as Mean±SE; N=6 in each case; * represent significant differences] 1148 
 1149 
Figure 6 - The effect of 16 weeks HFD on the AMPK activity of mouse SOL, EDL and DIA [Data 1150 
represented as Mean±SE; N=7 for SOL; N=6 for EDL; N=6 for DIA; * represent significant 1151 
differences] 1152 
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TABLES 1365 
 1366 
Table 1 - The effect of 16 weeks HFD on the anthropometric measures [Data represented as Mean±SE; 1367 
N= 30 & 29 lean & obese respectively, N=18 & 16 for lean and obese fat pad mass respectively; * 1368 
indicate significant differences between Lean and Obese groups] 1369 
 1370 
Table 2 - The effect of 16 weeks HFD on muscle group specific anthropometric measures [Data 1371 
represented as Mean±SE; N=10 for SOL; N=10 for EDL lean; N=9 for EDL obese; N=8 for DIA; * 1372 
represent significant differences between Lean and Obese groups] 1373 
 1374 
Table 3 – The effect of 16 weeks HFD on isometric time to half peak tetanus (THPT) and last stimulus 1375 
to half tetanus relaxation (LSHR) of isolated mouse SOL, EDL and DIA [Data represented as 1376 
Mean±SE; N=10 for SOL; N=10 for EDL lean; N=9 for EDL obese; N=8 for DIA; * represent 1377 
significant differences between Lean and Obese groups] 1378 
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TABLES 1425 
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 1427 
Table 1 - The effect of 16 weeks HFD on the anthropometric measures [Data represented as Mean±SE; 
N= 30 & 29 lean & obese respectively, N=18 & 16 for lean and obese fat pad mass respectively; * 
indicate significant differences between Lean and Obese groups] 
 Lean Obese 
BM (g) 38.5±1.00 52.7±2.30* 
Body Length (cm) 11.3±0.09 11.6±0.09 
BMI 0.30±0.01 0.39±0.01* 
Lee Index 0.30±0.00 0.32±0.02* 
Fat Pad Mass (g) 0.73±0.08 5.24±0.52* 
 1428 
 1429 
 1430 
 1431 
 1432 
 1433 
 1434 
 1435 
 1436 
 1437 
 1438 
 1439 
 1440 
 1441 
 1442 
 1443 
 1444 
 1445 
 1446 
 1447 
 1448 
 1449 
 1450 
 1451 
 1452 
 1453 
 1454 
 1455 
 1456 
 1457 
 1458 
 1459 
 1460 
 1461 
 1462 
 1463 
 1464 
 29 
 1465 
 1466 
 1467 
 1468 
 1469 
 1470 
 1471 
 1472 
 1473 
Table 2 - The effect of 16 weeks HFD on muscle group specific anthropometric measures [Data represented as 
Mean±SE; N=10 for SOL; N=10 for EDL lean; N=9 for EDL obese; N=8 for DIA; * represent significant differences 
between Lean and Obese groups] 
 BM (g) Body Length 
(cm) 
BMI Lee Index Muscle Mass (mg) Muscle Length (mm) 
SOL L 39.7±1.93 11.2±0.24 3.15±0.13 0.30±0.01 10.1±0.02 8.96±0.07 
SOL OB 52.0±1.90* 11.5±0.20 3.93±0.15* 0.32±0.01* 13.0±0.80* 9.07±0.19 
EDL L 35.5±1.2 11.2±0.08 2.84±0.00 0.29±0.00 10.0±0.03 9.26±0.40 
EDL OB 57.5±5.61* 11.6±0.14* 4.21±0.35* 0.33±0.01* 14.4±1.97* 8.45±0.25 
DIA L 40.9±1.34 11.6±0.09 3.05±0.02 0.30±0.00   
DIA OB 47.7±2.71* 11.0±0.15 3.59±0.15* 0.31±0.00*   
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Table 3 – The effect of 16 weeks HFD on isometric time to half peak tetanus (THPT) and last stimulus 
to half tetanus relaxation (LSHR) of isolated mouse SOL, EDL and DIA [Data represented as 
Mean±SE; N=10 for SOL; N=10 for EDL lean; N=9 for EDL obese; N=8 for DIA; * represent 
significant differences between Lean and Obese groups] 
 THPT (ms) LSHR (ms) 
 Lean Obese Lean Obese 
SOL 39.1±3.5 34.4±1.1 47.2±2.5 57.1±2.6* 
EDL 17.0±1.1 17.4±1.1 13.6±1.4 14.3±0.9 
DIA 26.1±1.8 25.0±1.1 28.1±1.8 23.8±0.8* 
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